These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33450231)

  • 1. Decreases in different Dnmt3b activities drive distinct development of hematologic malignancies in mice.
    Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Haney SL; Opavsky R
    J Biol Chem; 2021; 296():100285. PubMed ID: 33450231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-independent repression of Dnmt3b contributes to oncogenic activity of Dnmt3a in mouse MYC-induced T-cell lymphomagenesis.
    Haney SL; Hlady RA; Opavska J; Klinkebiel D; Pirruccello SJ; Dutta S; Datta K; Simpson MA; Wu L; Opavsky R
    Oncogene; 2015 Oct; 34(43):5436-5446. PubMed ID: 25639876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dnmt3b catalytic activity is critical for its tumour suppressor function in lymphomagenesis and is associated with c-Met oncogenic signalling.
    Lopusna K; Nowialis P; Opavska J; Abraham A; Riva A; Opavsky R
    EBioMedicine; 2021 Jan; 63():103191. PubMed ID: 33418509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis.
    Hlady RA; Novakova S; Opavska J; Klinkebiel D; Peters SL; Bies J; Hannah J; Iqbal J; Anderson KM; Siebler HM; Smith LM; Greiner TC; Bastola D; Joshi S; Lockridge O; Simpson MA; Felsher DW; Wagner KU; Chan WC; Christman JK; Opavsky R
    J Clin Invest; 2012 Jan; 122(1):163-77. PubMed ID: 22133874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical association of TET loss of function with genome-wide DNA hypomethylation.
    López-Moyado IF; Tsagaratou A; Yuita H; Seo H; Delatte B; Heinz S; Benner C; Rao A
    Proc Natl Acad Sci U S A; 2019 Aug; 116(34):16933-16942. PubMed ID: 31371502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role for Dnmt1 in the prevention and maintenance of MYC-induced T-cell lymphomas.
    Peters SL; Hlady RA; Opavska J; Klinkebiel D; Novakova S; Smith LM; Lewis RE; Karpf AR; Simpson MA; Wu L; Opavsky R
    Mol Cell Biol; 2013 Nov; 33(21):4321-33. PubMed ID: 24001767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA methyltransferases in hematological malignancies.
    Hoang NM; Rui L
    J Genet Genomics; 2020 Jul; 47(7):361-372. PubMed ID: 32994141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methyltransferase DNMT3b protein overexpression as a prognostic factor in patients with diffuse large B-cell lymphomas.
    Amara K; Ziadi S; Hachana M; Soltani N; Korbi S; Trimeche M
    Cancer Sci; 2010 Jul; 101(7):1722-30. PubMed ID: 20398054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.
    Okano M; Bell DW; Haber DA; Li E
    Cell; 1999 Oct; 99(3):247-57. PubMed ID: 10555141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia.
    Mizuno S; Chijiwa T; Okamura T; Akashi K; Fukumaki Y; Niho Y; Sasaki H
    Blood; 2001 Mar; 97(5):1172-9. PubMed ID: 11222358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catalytically inactive Dnmt3b rescues mouse embryonic development by accessory and repressive functions.
    Nowialis P; Lopusna K; Opavska J; Haney SL; Abraham A; Sheng P; Riva A; Natarajan A; Guryanova O; Simpson M; Hlady R; Xie M; Opavsky R
    Nat Commun; 2019 Sep; 10(1):4374. PubMed ID: 31558711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNMT1 and DNMT3B modulate distinct polycomb-mediated histone modifications in colon cancer.
    Jin B; Yao B; Li JL; Fields CR; Delmas AL; Liu C; Robertson KD
    Cancer Res; 2009 Sep; 69(18):7412-21. PubMed ID: 19723660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaempferol Modulates DNA Methylation and Downregulates DNMT3B in Bladder Cancer.
    Qiu W; Lin J; Zhu Y; Zhang J; Zeng L; Su M; Tian Y
    Cell Physiol Biochem; 2017; 41(4):1325-1335. PubMed ID: 28278502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inactive Dnmt3b3 isoform preferentially enhances Dnmt3b-mediated DNA methylation.
    Zeng Y; Ren R; Kaur G; Hardikar S; Ying Z; Babcock L; Gupta E; Zhang X; Chen T; Cheng X
    Genes Dev; 2020 Nov; 34(21-22):1546-1558. PubMed ID: 33004415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells.
    Duymich CE; Charlet J; Yang X; Jones PA; Liang G
    Nat Commun; 2016 Apr; 7():11453. PubMed ID: 27121154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis.
    Vasanthakumar A; Lepore JB; Zegarek MH; Kocherginsky M; Singh M; Davis EM; Link PA; Anastasi J; Le Beau MM; Karpf AR; Godley LA
    Blood; 2013 Mar; 121(11):2059-63. PubMed ID: 23315164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Dnmt3b accelerates MLL-AF9 leukemia progression.
    Zheng Y; Zhang H; Wang Y; Li X; Lu P; Dong F; Pang Y; Ma S; Cheng H; Hao S; Tang F; Yuan W; Zhang X; Cheng T
    Leukemia; 2016 Dec; 30(12):2373-2384. PubMed ID: 27133822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.
    Shah MY; Vasanthakumar A; Barnes NY; Figueroa ME; Kamp A; Hendrick C; Ostler KR; Davis EM; Lin S; Anastasi J; Le Beau MM; Moskowitz IP; Melnick A; Pytel P; Godley LA
    Cancer Res; 2010 Jul; 70(14):5840-50. PubMed ID: 20587527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
    Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
    Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.